Lee D, Jiang T, Crocker J, Way B
J Med Internet Res. 2023; 25:e46309.
PMID: 38064253
PMC: 10746962.
DOI: 10.2196/46309.
Andersen L, Palstrom N, Diederichsen A, Lindholt J, Rasmussen L, Beck H
Proteomes. 2021; 9(4).
PMID: 34941812
PMC: 8707687.
DOI: 10.3390/proteomes9040047.
Luo Y, Yan X, Xiao Q, Long Y, Pu J, Li Q
J Clin Lab Anal. 2021; 35(11):e24041.
PMID: 34606652
PMC: 8605144.
DOI: 10.1002/jcla.24041.
Connelly M, Otvos J, Shalaurova I, Playford M, Mehta N
J Transl Med. 2017; 15(1):219.
PMID: 29078787
PMC: 5658936.
DOI: 10.1186/s12967-017-1321-6.
Hansen I, Emamifar A, Andreasen R, Antonsen S
Medicine (Baltimore). 2017; 96(1):e5781.
PMID: 28072726
PMC: 5228686.
DOI: 10.1097/MD.0000000000005781.
Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.
Reiss W, Devenport J, Low J, Wu G, Sasso E
Rheumatol Int. 2015; 36(2):295-300.
PMID: 26026604
PMC: 4723630.
DOI: 10.1007/s00296-015-3285-2.
Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability.
Alexander K, Kazmierczak S, Snyder C, Oberdorf J, Farrell D
Clin Chem Lab Med. 2013; 51(9):1875-82.
PMID: 23648634
PMC: 4117345.
DOI: 10.1515/cclm-2012-0750.
Time variability of C-reactive protein: implications for clinical risk stratification.
Bogaty P, Dagenais G, Joseph L, Boyer L, Leblanc A, Belisle P
PLoS One. 2013; 8(4):e60759.
PMID: 23579782
PMC: 3620269.
DOI: 10.1371/journal.pone.0060759.
Repeating tests: different roles in research studies and clinical medicine.
Monach P
Biomark Med. 2012; 6(5):691-703.
PMID: 23075249
PMC: 3651832.
DOI: 10.2217/bmm.12.57.
Changing patterns of acute phase proteins and inflammatory mediators in experimental caprine coccidiosis.
Hashemnia M, Khodakaram-Tafti A, Razavi S, Nazifi S
Korean J Parasitol. 2011; 49(3):213-9.
PMID: 22072820
PMC: 3210837.
DOI: 10.3347/kjp.2011.49.3.213.
Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies.
Platz E, Sutcliffe S, De Marzo A, Drake C, Rifai N, Hsing A
Cancer Causes Control. 2010; 21(6):847-51.
PMID: 20135215
PMC: 3010861.
DOI: 10.1007/s10552-010-9511-z.
Biological variation of ischaemia-modified albumin in healthy subjects.
Govender R, De Greef J, Delport R, Becker P, Vermaak W
Cardiovasc J Afr. 2008; 19(3):141-4.
PMID: 18568173
PMC: 4650841.
Three-year change in inflammatory markers in elderly people and mortality: the Invecchiare in Chianti study.
Alley D, Crimmins E, Bandeen-Roche K, Guralnik J, Ferrucci L
J Am Geriatr Soc. 2007; 55(11):1801-7.
PMID: 17727645
PMC: 2646097.
DOI: 10.1111/j.1532-5415.2007.01390.x.
Urinary protein analysis in pre- and postoperative cancer patients.
Yokomizo K, Iijima S, Sakai N, Kurihara Y, Hitratsuka N, Nagai K
J Clin Lab Anal. 2005; 19(6):253-9.
PMID: 16302210
PMC: 6807788.
DOI: 10.1002/jcla.20087.
C-reactive protein levels in patients on maintenance hemodialysis: reliability and reflection on the utility of single measurements.
Stigant C, Djurdjev O, Levin A
Int Urol Nephrol. 2005; 37(1):133-40.
PMID: 16132776
DOI: 10.1007/s11255-004-2359-y.
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).
Munteanu M, Messous D, Thabut D, Imbert-Bismut F, Jouys M, Massard J
Comp Hepatol. 2004; 3(1):3.
PMID: 15214966
PMC: 449730.
DOI: 10.1186/1476-5926-3-3.
Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.
Sanchez P, Morinigo J, Pabon P, Martin F, Piedra I, Palacios I
Heart. 2004; 90(3):264-9.
PMID: 14966041
PMC: 1768109.
DOI: 10.1136/hrt.2002.007443.
Diagnostic strategies for C-reactive protein.
Riese H, Vrijkotte T, Meijer P, Kluft C, de Geus E
BMC Cardiovasc Disord. 2002; 2:9.
PMID: 12049676
PMC: 115848.
DOI: 10.1186/1471-2261-2-9.
Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature.
Ritchie R, Palomaki G, Neveux L, Navolotskaia O
J Clin Lab Anal. 2001; 14(6):265-70.
PMID: 11138607
PMC: 6807951.
Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: a comparison of a large cohort to the world's literature.
Ritchie R, Palomaki G, Neveux L, Navolotskaia O
J Clin Lab Anal. 2000; 13(6):280-6.
PMID: 10633295
PMC: 6807761.